Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo

被引：0
|
作者：
Takeshi Fukumoto
Susumu Fujiwara
Masanobu Sakaguchi
Masahiro Oka
Naomi Kiyota
Yasuo Ejima
Koichi Nakajima
Chikako Nishigori
机构：
[1] Kobe University Graduate School of Medicine,Division of Dermatology, Department of Internal Related
[2] Kobe University Graduate School of Medicine,Division of Medical Oncology/Hematology, Department of Medicine
[3] Kobe University Graduate School of Medicine,Division of Radiation Oncology
[4] Shiso Municipal Hospital,Division of Surgery
来源：
European Journal of Dermatology | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：177 / 178
页数：1
相关论文
共 50 条
  • [1] Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo
    Fukumoto, Takeshi
    Fujiwara, Susumu
    Sakaguchi, Masanobu
    Oka, Masahiro
    Kiyota, Naomi
    Ejima, Yasuo
    Nakajima, Koichi
    Nishigori, Chikako
    EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (02) : 177 - 178
  • [2] Vitiligo of the Face in a Patient Treated With Vemurafenib for Metastatic Melanoma
    Nasca, Maria Rita
    Lacarrubba, Francesco
    Ferrau, Francesco
    Micali, Giuseppe
    JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (06) : 766 - 768
  • [3] Long-term Survival in Metastatic Malignant Melanoma: Ipilimumab Followed by Vemurafenib in a Patient with Brain Metastasis
    Balakan, Ozan
    Suner, Ali
    Yigiter, Remzi
    Balakan, Tuba
    Sirikci, Akif
    Sevinc, Alper
    INTERNAL MEDICINE, 2012, 51 (19) : 2819 - 2823
  • [4] Long-Term Survival in Patients with Metastatic Melanoma Treated with DTIC or Temozolomide
    Kim, Christina
    Lee, Christopher W.
    Kovacic, Laurel
    Shah, Amil
    Klasa, Richard
    Savage, Kerry J.
    ONCOLOGIST, 2010, 15 (07): : 765 - 771
  • [5] Evaluation of the Long-Term Survival after Treatment with Ipilimumab or Vemurafenib in Patients with Metastatic Malignant Melanoma
    Rudolph, B. M.
    Groffik, A.
    Faidt, D.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 2 - 3
  • [6] Long-Term Response to Vemurafenib Therapy in Patients with metastatic malignant Melanoma
    Groffik, A.
    Mueller-Brenne, T.
    Rudolph, B.
    Rietz, S.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 908 - 908
  • [7] Long-term survival of a metastatic cerebral melanoma
    Banayan, A
    Vital, C
    NEUROCHIRURGIE, 1998, 44 (04) : 275 - 277
  • [8] Long-term control of leptomeningeal disease after radiation therapy and nivolumab in a metastatic melanoma patient
    Wu, Richard C.
    Newman, William
    Patanowitz, Liron
    Branstetter, Barton F.
    Amankulor, Nduka
    Tarhini, Ahmad A.
    IMMUNOTHERAPY, 2020, 12 (11) : 763 - 769
  • [9] Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: a case report
    Lee, Jee Min
    Mehta, Urvi N.
    Dsouza, Ly H.
    Guadagnolo, Beverly Ashleigh
    Sanders, Deborah L.
    Kim, Kevin B.
    MELANOMA RESEARCH, 2013, 23 (02) : 175 - 178
  • [10] Nivolumab-induced vitiligo in a metastatic melanoma patient: A case report
    Edmondson, Lindsay A.
    Smith, Leticia V.
    Mallik, Alka
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (08) : 629 - 634
12345